CYPEX
LIVE

Serial Number

76608647

Owner

Cypex Limited

Attorney

Michele M. Glessner

Filing Date

Aug 25, 2004

Add to watchlist:

No watchlists yet
View on USPTO

CYPEX Trademark

Serial Number: 76608647 • Registration: 3235547

CYPEX is a trademark filed by Cypex Limited on August 25, 2004. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Cypex Limited (3 trademarks)

6 Tom McDonald Avenue
Dundee DD2 1NH , GB

Entity Type: 03

Trademark Details

Filing Date

August 25, 2004

Registration Date

May 1, 2007

Published for Opposition

February 13, 2007

Goods & Services

[BIOCHEMICAL PREPARATIONS FOR MEDICAL OR VETERINARY USE, NAMELY, MONOCLONAL ANTIBODIES, POLYCLONAL ANTIBODIES, TAGGED ANTIBODIES, RECOMBINANT PROTEIN, ENZYMES, RECOMBINANT HUMAN ENZYMES, RECOMBINANT HUMAN ENZYMES IN BACTERIA, RECOMBINANT HUMAN DRUG-METABOLIZING ENZYMES; REAGENTS FOR USE IN DEVELOPMENT OF MONOCLONAL ANTIBODIES FOR MEDICAL USE; REAGENTS FOR USE IN DEVELOPMENT OF POLYCLONAL ANTIBODIES FOR MEDICAL USE; CHEMICAL PREPARATIONS CONTAINING ENZYMES FOR MEDICAL PURPOSES; CHEMICAL PREPARATIONS CONTAINING ENZYMES FOR PHARMACEUTICAL PURPOSES; ASSAYS FOR MEDICAL USE; BACTERIAL PRODUCTS, NAMELY, BACTERIAL CULTURES FOR MEDICAL USE; BACTERIAL PREPARATIONS FOR MEDICAL USE; BACTERIAL VACCINES FOR MEDICAL USE; BACTERIAL MEMBRANES FOR MEDICAL USE; REAGENTS IN KIT FORM FOR MEDICAL USE]

BIOCHEMICAL PREPARATIONS, NAMELY, MONOCLONAL ANTIBODIES FOR IN VITRO SCIENTIFIC OR RESEARCH USE, POLYCLONAL ANTIBODIES FOR IN VITRO SCIENTIFIC OR RESEARCH USE, RECOMBINANT PROTEIN, ENZYMES, RECOMBINANT HUMAN ENZYMES, RECOMBINANT HUMAN ENZYMES IN BACTERIA, RECOMBINANT HUMAN DRUG-METABOLIZING ENZYMES, METABOLITES, ALL FOR SCIENTIFIC OR RESEARCH USE; REAGENTS FOR USE IN DEVELOPMENT OF POLYCLONAL ANTIBODIES FOR SCIENTIFIC OR RESEARCH USE; BACTERIAL PREPARATIONS FOR SCIENTIFIC OR RESEARCH USE; ASSAYS FOR SCIENTIFIC OR RESEARCH USE

SCIENTIFIC RESEARCH SERVICES IN THE FIELD OF BIOTECHNOLOGY, NAMELY, DRUG METABOLITE SYNTHESIS, HETEROLOGOUS PROTEIN EXPRESSION, IN VITRO DRUG METABOLISM SYSTEMS, PRODUCTION OF RECOMBINANT PROTEIN, PRODUCTION OF RECOMBINANT HUMAN ENZYMES, PRODUCTION OF RECOMBINANT HUMAN ENZYMES IN BACTERIA, PRODUCTION OF RECOMBINANT HUMAN DRUG-METABOLIZING ENZYMES; SCIENTIFIC RESEARCH CONSULTATION

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Jun 10, 2017 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Jun 10, 2017 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Jun 10, 2017 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 10, 2017 APRE
TEAS SECTION 8 & 9 RECEIVED
Apr 18, 2017 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
May 1, 2016 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Aug 27, 2012 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Aug 26, 2012 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 26, 2012 APRE
TEAS SECTION 8 & 15 RECEIVED
Aug 8, 2012 E815
REGISTERED-PRINCIPAL REGISTER
May 1, 2007 R.PR
PUBLISHED FOR OPPOSITION
Feb 13, 2007 PUBO
NOTICE OF PUBLICATION
Jan 24, 2007 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Dec 20, 2006 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 19, 2006 CNSA
AMENDMENT FROM APPLICANT ENTERED
Dec 4, 2006 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 4, 2006 CRFA
ASSIGNED TO LIE
Dec 4, 2006 ALIE
PAPER RECEIVED
Nov 13, 2006 MAIL
INQUIRY AS TO SUSPENSION MAILED
May 12, 2006 CNSI
SUSPENSION INQUIRY WRITTEN
May 12, 2006 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
May 11, 2006 RCCK
CORRESPONDENCE MAILED
Oct 27, 2005 CRML
SUSPENSION LETTER WRITTEN
Oct 27, 2005 CNSL
AMENDMENT FROM APPLICANT ENTERED
Oct 6, 2005 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 28, 2005 CRFA
PAPER RECEIVED
Sep 28, 2005 MAIL
NON-FINAL ACTION MAILED
Mar 28, 2005 CNRT
NON-FINAL ACTION WRITTEN
Mar 25, 2005 CNRT
ASSIGNED TO EXAMINER
Mar 25, 2005 DOCK
NEW APPLICATION ENTERED
Sep 3, 2004 NWAP